Sweden· SE-19870612000136
Haemate 1000 IE FVIII/ 2400 IE VWF Pulver och vätska till injektions-/infusionsvätska, lösning
A medicinal product containing human coagulation factor viii + human von willebrand factor, registered in Sweden by CSL Behring GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Human Coagulation Factor Viii + Human Von Willebrand Factor
- Manufacturer
- CSL Behring GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19870612000136
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Human coagulation factor viii + human von willebrand factor in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandHaemateAbacus Medicine A/S
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- NorwayHaemateCSL Behring GmbH
- IrelandVoncento 1000 IU/2400 IU Powder and solvent for solution for injection/infusionCSL Behring GmbH
- IcelandVoncentoCSL Behring GmbH*
- CanadaHUMATE-PCSL BEHRING CANADA INC
- GermanyHaemate PCsl Behring Gmbh
- United StatesWilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human)Octapharma USA Inc
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Haemate P, Immunate
- Belgium · Haemate P, Wilate
- Bulgaria · Wilate, Имунейт
- Cyprus · Haemate P, Immunate
- Czechia · Fanhdi, Haemate P
- Germany · Haemate P, Immunate
- Denmark · Haemate, Wilnativ
- Estonia · Haemate, Immunate
- Spain · Fanhdi, Haemate P
- Finland · Haemate, Haemwill
- France · Eqwilate
- United Kingdom (Northern Ireland) · Alphanate, Dried Factor Viii Fraction Type 8y Bio Products Laboratory
- Greece · Haemate P
- Croatia · Fanhdi, Haemate P
- Hungary · Haemate P, Immunate S/D
- Ireland · Wilate
- Iceland · Voncento
- Italy · Alphanate, Fanhdi
- Liechtenstein · Voncento
- Lithuania · Haemate, Immunate
- Luxembourg · Haemate P, Wilate
- Latvia · Haemate, Immunate
- Malta · Immunate, Wilate
- Netherlands · Haemate P, Wilate
- Norway · Haemate, Voncento
- Poland · Fanhdi, Haemate P
- Portugal · Haemate P, Immunate
- Romania · Haemate P, Immunate
- Slovenia · Haemate P, Immunate
- Slovakia · Fanhdi, Haemate P
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c56ab8b1-6fee-4855-97b1-5e4b0b863a8e GET /v1/drugs/c56ab8b1-6fee-4855-97b1-5e4b0b863a8e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19870612000136",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19870612000136",
"product_doc_link": "https://docetp.mpa.se/LMF/Haemate%20powder%20and%20solvent%20for%20solution%20for%20injection%20SmPC_09001bee807a30d0.pdf"
}See everything about human coagulation factor viii + human von willebrand factor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.